CG Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-139
Closed -$11K 128
2015
Q4
$11K Sell
139
-1,116
-89% -$550K ﹤0.01% 112
2015
Q3
$842K Buy
1,255
+203
+19% +$144K 0.36% 69
2015
Q2
$701K Buy
1,052
+276
+36% +$182K 0.27% 84
2015
Q1
$520K Buy
+776
New +$511K 0.2% 91
2014
Q2
Sell
-64
Closed -$50K 143
2014
Q1
$50K Buy
+64
New +$52K 0.02% 127

Other funds holding MTEM

CG Asset Management's MTEM Position: Q1 2016 in Review

CG Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q1 2016, closing a stake of 139 shares — an estimated $11K sold.

CG Asset Management first reported a position in MTEM in Q1 2014 and held it in 5 quarters. The position peaked at $842K in Q3 2015. 70 funds tracked by Wall St. Rank hold MTEM as of Q1 2016.

  • CG Asset Management reported no remaining Molecular Templates, Inc. position as of Q1 2016 after selling out during the quarter.
  • CG Asset Management sold 139 Molecular Templates, Inc. shares in Q1 2016, an estimated $11K.
  • CG Asset Management first reported a position in Molecular Templates, Inc. in Q1 2014 and held it in 5 quarters.
  • CG Asset Management's Molecular Templates, Inc. position peaked at $842K in Q3 2015.
  • 70 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2016.

Based on CG Asset Management's 13F filing for Q1 2016, filed 10 May 2016.